883 filings
Page 2 of 45
8-K
pn0eskv ygj1w
13 Nov 23
Delcath Systems Reports Third Quarter 2023 Results and Provides Business Update
4:10pm
8-K
f1lk6 y59s6tc
6 Sep 23
Regulation FD Disclosure
4:32pm
424B3
tqemyz 6o3tlu60frm4
1 Sep 23
Prospectus supplement
4:01pm
8-K
3k53rkd4f zi
15 Aug 23
HEPZATO KIT is the only FDA approved liver-directed therapy to treat metastatic uveal melanoma
6:57am
8-K
hy8p7 rrcjk0n5
9 Aug 23
Delcath Systems Reports Second Quarter 2023 Results and Provides Business Update
5:23pm
8-K
rsb30dno n1s
4 Aug 23
Regulation FD Disclosure
5:30pm
EFFECT
9m6823 qzw3hzkl6chva
29 Jun 23
Notice of effectiveness
12:15am
424B3
ajdbx3zqn1tp v06
28 Jun 23
Prospectus supplement
4:55pm
CORRESP
4pjg8 6daxsln
26 Jun 23
Correspondence with SEC
12:00am
8-K
jsffc7c ue2e
22 Jun 23
Other Events
4:06pm
UPLOAD
gwj 9uhx2co
21 Jun 23
Letter from SEC
12:00am
8-K
ze2kkke
13 Jun 23
Departure of Directors or Certain Officers
4:39pm
8-K
gu4i95ycegvtat4c
7 Jun 23
Delcath Systems Announces Sandra Pennell as Senior Vice President of Finance
4:41pm
NT 10-Q
8v22rvocvj123bfw8n4
12 May 23
Notice of late quarterly filing
4:07pm
8-K
zr5z7j3m jnajva2z666
12 May 23
Delcath Systems Provides Business Update and Reports Preliminary First Quarter 2023 Financial Results
8:08am
ARS
oyt6mc6u2 irk167t
1 May 23
Annual report to shareholders
8:05am